NCT02032160View on ClinicalTrials.gov

"A Study to Characterise Immune Responses Following Immunisations With Fendrix or Engerix B Hepatitis B Vaccines"

NACompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

May 31, 2014

Primary Completion Date

February 29, 2016

Study Completion Date

February 29, 2016

Conditions
Hepatitis B
Interventions
BIOLOGICAL

Engerix B IM injection - 20ug

Engerix B IM injection - 20ug At 0, 1 and 6 months

BIOLOGICAL

Fendrix IM injection - 20ug

Fendrix IM injection - 20ug At 0, 1 and 6 months

Trial Locations (1)

Gu2 7XP

Surrey Clinical Research Centre, Guildford

All Listed Sponsors
lead

University of Surrey

OTHER

NCT02032160 - "A Study to Characterise Immune Responses Following Immunisations With Fendrix or Engerix B Hepatitis B Vaccines" | Biotech Hunter | Biotech Hunter